Tandem Diabetes Care Inc (FRA:TD5A)
€ 45.11 0.18 (0.4%) Market Cap: 3.06 Bil Enterprise Value: 3.07 Bil PE Ratio: 0 PB Ratio: 13.10 GF Score: 78/100

Tandem Diabetes Care Inc at Piper Sandler Healthcare Conference Transcript

Nov 30, 2022 / 02:00PM GMT
Release Date Price: €38.53 (-2.53%)
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

All right. Good morning, everybody. Thanks so much for joining us. I'm Matt O'Brien. I cover MedTech here at Piper. Really excited to have the Tandem management team here with us from the company is John the CEO; and then Leigh the CFO. Thanks so much for the time. I appreciate it.

Questions & Answers

Matthew Oliver O;Brien;John F. Sheridan
Piper Sandler & Co., Research Division - MD & Senior Research Analyst;Tandem Diabetes Care, Inc. - President, CEO & Director<

' -

Let's talk about the third quarter, which I'm sure you're tired of talking about, but it was a difficult time for the company. The September quarter really seemed to slow and it was surprising. It seemed like August went well and then September slowed down and what was it that really affected the company in September that made you decide to go ahead and lower expectations for not only just Q4 but also '23 as well?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot